Institute seminar October 8th 12:00 Randi Syljuåasen

Apsana L, Benedikte AS, Unni N, Jayne KN, Je SR, Geir B, Kristine P (2025)
A role of arginase-1-expressing myeloid cells in cachexia
Cancer Metab, 13 (1), 27
DOI 10.1186/s40170-025-00396-0, PubMed 40474277

Andresen S, Al Outa A, Formica M, Enserink J, Knævelsrud H (2025)
Improved detection of lipidated Atg8a by immunoblotting in drosophila melanogaster cells and tissues enables precise investigation of Atg8a flux and its termination
Autophagy (in press)
DOI 10.1080/15548627.2025.2508551, PubMed 40426043

Høyvik AJK, Kvassheim M, Ma LW, Wiig E, Hillestad T, Revheim ME, Liukaityte R, Bruland Ø, Juzeniene A (2025)
Therapeutic evaluation of [²¹²Pb]Pb-AB001 and [¹⁷⁷Lu]Lu-PSMA-617 in a mouse model of disseminated prostate cancer
Eur J Nucl Med Mol Imaging (in press)
DOI 10.1007/s00259-025-07330-y, PubMed 40397137

Bouska A, Zhang W, Sharma S, Holte H, Shah RA, Lone WG, Soma MA, Yang R, Liu X, Mehmood S, Chawla RS, Cappelli LV, Fiore D, Gong Q, Heavican-Foral TB, Cannatella JJ, Amador C, Arif A, Smith LM, Lim ST, Ong CK, Feldman AL, Du MQ, Perry AM, de Leval L et al. (2025)
Integrative Genomic and Transcriptomic Analysis Reveals Targetable Vulnerabilities in Angioimmunoblastic T-Cell Lymphoma
Am J Hematol (in press)
DOI 10.1002/ajh.27736, PubMed 40510016

Al Haidari G, Solbakken AM, Ã…sli LM, Skovlund E, Undseth C, Guren MG (2025)
Treatment and outcomes for locally recurrent rectal cancer in Norway
Acta Oncol, 64, 784-792
DOI 10.2340/1651-226X.2025.42991, PubMed 40500960

Lindland K, Westrøm S, Dragovic SM, Li RG, Malenge MM, Ho B, Juzeniene A, Bønsdorff TB (2025)
Preclinical Evaluation of PTK7-Targeted Radionuclide Therapy
Mol Cancer Ther (in press)
DOI 10.1158/1535-7163.MCT-24-1060, PubMed 40495114